Fix `license` metadata

#1
by julien-c HF staff - opened
Files changed (1) hide show
  1. README.md +496 -498
README.md CHANGED
@@ -1,499 +1,497 @@
1
- ---
2
- license: apache-2.0
3
- annotations_creators:
4
- - expert-generated
5
- language_creators:
6
- - expert-generated
7
- languages:
8
- - en
9
- licenses:
10
- - unknown
11
- multilinguality:
12
- - monolingual
13
- paperswithcode_id: null
14
- pretty_name: BLURB (Biomedical Language Understanding and Reasoning Benchmark.)
15
- size_categories:
16
- - 10K<n<100K
17
- source_datasets:
18
- - original
19
- task_categories:
20
- - structure-prediction
21
- - question-answering
22
- - text-scoring
23
- - text-classification
24
- task_ids:
25
- - named-entity-recognition
26
- - parsing
27
- - closed-domain-qa
28
- - semantic-similarity-scoring
29
- - text-scoring-other-sentence-similrity
30
- - topic-classificatio
31
- ---
32
-
33
- # Dataset Card for BLURB
34
-
35
- ## Table of Contents
36
- - [Table of Contents](#table-of-contents)
37
- - [Dataset Description](#dataset-description)
38
- - [Dataset Summary](#dataset-summary)
39
- - [Supported Tasks and Leaderboards](#supported-tasks-and-leaderboards)
40
- - [Languages](#languages)
41
- - [Dataset Structure](#dataset-structure)
42
- - [Data Instances](#data-instances)
43
- - [Data Fields](#data-fields)
44
- - [Data Splits](#data-splits)
45
- - [Dataset Creation](#dataset-creation)
46
- - [Curation Rationale](#curation-rationale)
47
- - [Source Data](#source-data)
48
- - [Annotations](#annotations)
49
- - [Personal and Sensitive Information](#personal-and-sensitive-information)
50
- - [Considerations for Using the Data](#considerations-for-using-the-data)
51
- - [Social Impact of Dataset](#social-impact-of-dataset)
52
- - [Discussion of Biases](#discussion-of-biases)
53
- - [Other Known Limitations](#other-known-limitations)
54
- - [Additional Information](#additional-information)
55
- - [Dataset Curators](#dataset-curators)
56
- - [Licensing Information](#licensing-information)
57
- - [Citation Information](#citation-information)
58
- - [Contributions](#contributions)
59
-
60
- ## Dataset Description
61
-
62
- - **Homepage:** https://microsoft.github.io/BLURB/index.html
63
- - **Paper:** [Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing](https://arxiv.org/pdf/2007.15779.pdf)
64
- - **Leaderboard:** https://microsoft.github.io/BLURB/leaderboard.html
65
- - **Point of Contact:**
66
-
67
- ### Dataset Summary
68
-
69
- BLURB is a collection of resources for biomedical natural language processing. In general domains, such as newswire and the Web, comprehensive benchmarks and leaderboards such as GLUE have greatly accelerated progress in open-domain NLP. In biomedicine, however, such resources are ostensibly scarce. In the past, there have been a plethora of shared tasks in biomedical NLP, such as BioCreative, BioNLP Shared Tasks, SemEval, and BioASQ, to name just a few. These efforts have played a significant role in fueling interest and progress by the research community, but they typically focus on individual tasks. The advent of neural language models, such as BERT provides a unifying foundation to leverage transfer learning from unlabeled text to support a wide range of NLP applications. To accelerate progress in biomedical pretraining strategies and task-specific methods, it is thus imperative to create a broad-coverage benchmark encompassing diverse biomedical tasks.
70
-
71
- Inspired by prior efforts toward this direction (e.g., BLUE), we have created BLURB (short for Biomedical Language Understanding and Reasoning Benchmark). BLURB comprises of a comprehensive benchmark for PubMed-based biomedical NLP applications, as well as a leaderboard for tracking progress by the community. BLURB includes thirteen publicly available datasets in six diverse tasks. To avoid placing undue emphasis on tasks with many available datasets, such as named entity recognition (NER), BLURB reports the macro average across all tasks as the main score. The BLURB leaderboard is model-agnostic. Any system capable of producing the test predictions using the same training and development data can participate. The main goal of BLURB is to lower the entry barrier in biomedical NLP and help accelerate progress in this vitally important field for positive societal and human impact.
72
-
73
-
74
- #### BC5-chem
75
- The corpus consists of three separate sets of
76
- articles with diseases, chemicals and their relations annotated.
77
- The training (500 articles) and development (500 articles) sets
78
- were released to task participants in advance to support text-mining
79
- method development. The test set (500 articles) was used for final
80
- system performance evaluation.
81
-
82
- - **Homepage:** https://biocreative.bioinformatics.udel.edu/resources/corpora/biocreative-v-cdr-corpus
83
- - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
84
- - **Paper:** [BioCreative V CDR task corpus: a resource for chemical disease relation extraction](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860626/)
85
-
86
- #### BC5-disease
87
- The corpus consists of three separate sets of
88
- articles with diseases, chemicals and their relations annotated.
89
- The training (500 articles) and development (500 articles) sets
90
- were released to task participants in advance to support text-mining
91
- method development. The test set (500 articles) was used for final
92
- system performance evaluation.
93
-
94
- - **Homepage:** https://biocreative.bioinformatics.udel.edu/resources/corpora/biocreative-v-cdr-corpus
95
- - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
96
- - **Paper:** [BioCreative V CDR task corpus: a resource for chemical disease relation extraction](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860626/)
97
-
98
- #### BC2GM
99
- The BioCreative II Gene Mention task.
100
- The training corpus for the current task consists mainly of
101
- the training and testing corpora (text collections) from the
102
- BCI task, and the testing corpus for the current task
103
- consists of an additional 5,000 sentences that were held
104
- 'in reserve' from the previous task.
105
- In the current corpus, tokenization is not provided;
106
- instead participants are asked to identify a gene mention
107
- in a sentence by giving its start and end characters.
108
- As before, the training set consists of a set of sentences,
109
- and for each sentence a set of gene mentions
110
- (GENE annotations).
111
- - **Homepage:** https://biocreative.bioinformatics.udel.edu/tasks/biocreative-ii/task-1a-gene-mention-tagging/
112
- - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
113
- - **Paper:** [verview of BioCreative II gene mention recognition](https://link.springer.com/article/10.1186/gb-2008-9-s2-s2)
114
-
115
- #### NCBI Disease
116
-
117
- The NCBI disease corpus is fully annotated at the mention
118
- and concept level to serve as a research resource for the biomedical natural
119
- language processing community.
120
- Corpus Characteristics
121
- ----------------------
122
- * 793 PubMed abstracts
123
- * 6,892 disease mentions
124
- * 790 unique disease concepts
125
- * Medical Subject Headings (MeSH®)
126
- * Online Mendelian Inheritance in Man (OMIM®)
127
- * 91% of the mentions map to a single disease concept
128
- **divided into training, developing and testing sets.
129
- Corpus Annotation
130
- * Fourteen annotators
131
- * Two-annotators per document (randomly paired)
132
- * Three annotation phases
133
- * Checked for corpus-wide consistency of annotations
134
- - **Homepage:** https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/
135
- - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
136
- - **Paper:** [NCBI disease corpus: a resource for disease name recognition and concept normalization](https://pubmed.ncbi.nlm.nih.gov/24393765/)
137
-
138
- #### JNLPBA
139
- The BioNLP / JNLPBA Shared Task 2004 involves the identification
140
- and classification of technical terms referring to concepts of interest to
141
- biologists in the domain of molecular biology. The task was organized by GENIA
142
- Project based on the annotations of the GENIA Term corpus (version 3.02).
143
- Corpus format: The JNLPBA corpus is distributed in IOB format, with each line
144
- containing a single token and its tag, separated by a tab character.
145
- Sentences are separated by blank lines.
146
- - **Homepage: ** http://www.geniaproject.org/shared-tasks/bionlp-jnlpba-shared-task-2004
147
- - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
148
- - **Paper: ** [Introduction to the Bio-entity Recognition Task at JNLPBA](https://aclanthology.org/W04-1213)
149
-
150
- #### EBM PICO
151
- - **Homepage:**
152
- - **Repository:**
153
- - **Paper:**
154
- - **Leaderboard:**
155
-
156
- #### ChemProt
157
- - **Homepage:**
158
- - **Repository:**
159
- - **Paper:**
160
-
161
- #### DDI
162
- - **Homepage:**
163
- - **Repository:**
164
- - **Paper:**
165
-
166
- #### GAD
167
- - **Homepage:**
168
- - **Repository:**
169
- - **Paper:**
170
-
171
- #### BIOSSES
172
-
173
- BIOSSES is a benchmark dataset for biomedical sentence similarity estimation. The dataset comprises 100 sentence pairs, in which each sentence was selected from the [TAC (Text Analysis Conference) Biomedical Summarization Track Training Dataset](https://tac.nist.gov/2014/BiomedSumm/) containing articles from the biomedical domain. The sentence pairs in BIOSSES were selected from citing sentences, i.e. sentences that have a citation to a reference article.
174
- The sentence pairs were evaluated by five different human experts that judged their similarity and gave scores ranging from 0 (no relation) to 4 (equivalent). In the original paper the mean of the scores assigned by the five human annotators was taken as the gold standard. The Pearson correlation between the gold standard scores and the scores estimated by the models was used as the evaluation metric. The strength of correlation can be assessed by the general guideline proposed by Evans (1996) as follows:
175
- - very strong: 0.801.00
176
- - strong: 0.60–0.79
177
- - moderate: 0.40–0.59
178
- - weak: 0.20–0.39
179
- - very weak: 0.00–0.19
180
-
181
- - **Homepage:** https://tabilab.cmpe.boun.edu.tr/BIOSSES/DataSet.html
182
- - **Repository:** https://github.com/gizemsogancioglu/biosses
183
- - **Paper:** [BIOSSES: a semantic sentence similarity estimation system for the biomedical domain](https://academic.oup.com/bioinformatics/article/33/14/i49/3953954)
184
- - **Point of Contact:** [Gizem Soğancıoğlu](gizemsogancioglu@gmail.com) and [Arzucan Özgür](gizemsogancioglu@gmail.com)
185
-
186
- #### HoC
187
- - **Homepage:**
188
- - **Repository:**
189
- - **Paper:**
190
- - **Leaderboard:**
191
- - **Point of Contact:**
192
-
193
-
194
- #### PubMedQA
195
-
196
- We introduce PubMedQA, a novel biomedical question answering (QA) dataset collected from PubMed abstracts. The task of PubMedQA is to answer research questions with yes/no/maybe (e.g.: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?) using the corresponding abstracts. PubMedQA has 1k expert-annotated, 61.2k unlabeled and 211.3k artificially generated QA instances. Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion. PubMedQA is the first QA dataset where reasoning over biomedical research texts, especially their quantitative contents, is required to answer the questions. Our best performing model, multi-phase fine-tuning of BioBERT with long answer bag-of-word statistics as additional supervision, achieves 68.1% accuracy, compared to single human performance of 78.0% accuracy and majority-baseline of 55.2% accuracy, leaving much room for improvement. PubMedQA is publicly available at this https URL.
197
-
198
- - **Homepage:** https://pubmedqa.github.io/
199
- - **Repository:** https://github.com/pubmedqa/pubmedqa
200
- - **Paper:** [PubMedQA: A Dataset for Biomedical Research Question Answering](https://arxiv.org/pdf/1909.06146.pdf)
201
- - **Leaderboard:** [Question answering](https://pubmedqa.github.io/)
202
- - **Point of Contact:**
203
-
204
- #### BioASQ
205
-
206
- Task 7b will use benchmark datasets containing training and test biomedical questions, in English, along with gold standard (reference) answers. The participants will have to respond to each test question with relevant concepts (from designated terminologies and ontologies), relevant articles (in English, from designated article repositories), relevant snippets (from the relevant articles), relevant RDF triples (from designated ontologies), exact answers (e.g., named entities in the case of factoid questions) and 'ideal' answers (English paragraph-sized summaries). 2747 training questions (that were used as dry-run or test questions in previous year) are already available, along with their gold standard answers (relevant concepts, articles, snippets, exact answers, summaries).
207
-
208
- - **Homepage:** http://bioasq.org/
209
- - **Repository:** http://participants-area.bioasq.org/datasets/
210
- - **Paper:** [Automatic semantic classification of scientific literature according to the hallmarks of cancer](https://academic.oup.com/bioinformatics/article/32/3/432/1743783?login=false)
211
-
212
- ### Supported Tasks and Leaderboards
213
-
214
- | **Dataset** | **Task** | **Train** | **Dev** | **Test** | **Evaluation Metrics** | **Added** |
215
- |:------------:|:-----------------------:|:---------:|:-------:|:--------:|:----------------------:|-----------|
216
- | BC5-chem | NER | 5203 | 5347 | 5385 | F1 entity-level | **Yes** |
217
- | BC5-disease | NER | 4182 | 4244 | 4424 | F1 entity-level | **Yes** |
218
- | NCBI-disease | NER | 5134 | 787 | 960 | F1 entity-level | **Yes** |
219
- | BC2GM | NER | 15197 | 3061 | 6325 | F1 entity-level | **Yes** |
220
- | JNLPBA | NER | 46750 | 4551 | 8662 | F1 entity-level | **Yes** |
221
- | EBM PICO | PICO | 339167 | 85321 | 16364 | Macro F1 word-level | No |
222
- | ChemProt | Relation Extraction | 18035 | 11268 | 15745 | Micro F1 | No |
223
- | DDI | Relation Extraction | 25296 | 2496 | 5716 | Micro F1 | No |
224
- | GAD | Relation Extraction | 4261 | 535 | 534 | Micro F1 | No |
225
- | BIOSSES | Sentence Similarity | 64 | 16 | 20 | Pearson | **Yes** |
226
- | HoC | Document Classification | 1295 | 186 | 371 | Average Micro F1 | No |
227
- | PubMedQA | Question Answering | 450 | 50 | 500 | Accuracy | **Yes** |
228
- | BioASQ | Question Answering | 670 | 75 | 140 | Accuracy | No |
229
-
230
- Datasets used in the BLURB biomedical NLP benchmark. The Train, Dev, and test splits might not be exactly identical to those proposed in BLURB.
231
- This is something to be checked.
232
-
233
- ### Languages
234
-
235
- English from biomedical texts
236
-
237
- ## Dataset Structure
238
-
239
- ### Data Instances
240
-
241
- * **NER**
242
- ```json
243
- {
244
- 'id': 0,
245
- 'tokens': [ "DPP6", "as", "a", "candidate", "gene", "for", "neuroleptic", "-", "induced", "tardive", "dyskinesia", "." ]
246
- 'ner_tags': [ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
247
- }
248
- ```
249
- * **PICO**
250
- ```json
251
- {
252
- 'TBD'
253
- }
254
- ```
255
- * **Relation Extraction**
256
- ```json
257
- {
258
- 'TBD'
259
- }
260
- ```
261
-
262
- * **Sentence Similarity**
263
-
264
- ```json
265
- {'sentence 1': 'Here, looking for agents that could specifically kill KRAS mutant cells, they found that knockdown of GATA2 was synthetically lethal with KRAS mutation'
266
- 'sentence 2': 'Not surprisingly, GATA2 knockdown in KRAS mutant cells resulted in a striking reduction of active GTP-bound RHO proteins, including the downstream ROCK kinase'
267
- 'score': 2.2}
268
- ```
269
-
270
- * **Document Classification**
271
- ```json
272
- {
273
- 'TBD'
274
- }
275
- ```
276
- * **Question Answering**
277
-
278
- * PubMedQA
279
- ```json
280
- {'context': {'contexts': ['Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.',
281
- 'The following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (ΔΨm). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.'],
282
- 'labels': ['BACKGROUND', 'RESULTS'],
283
- 'meshes': ['Alismataceae',
284
- 'Apoptosis',
285
- 'Cell Differentiation',
286
- 'Mitochondria',
287
- 'Plant Leaves'],
288
- 'reasoning_free_pred': ['y', 'e', 's'],
289
- 'reasoning_required_pred': ['y', 'e', 's']},
290
- 'final_decision': 'yes',
291
- 'long_answer': 'Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace plant, and highlight the correlation of this organelle with other organelles during developmental PCD. To the best of our knowledge, this is the first report of mitochondria and chloroplasts moving on transvacuolar strands to form a ring structure surrounding the nucleus during developmental PCD. Also, for the first time, we have shown the feasibility for the use of CsA in a whole plant system. Overall, our findings implicate the mitochondria as playing a critical and early role in developmentally regulated PCD in the lace plant.',
292
- 'pubid': 21645374,
293
- 'question': 'Do mitochondria play a role in remodelling lace plant leaves during programmed cell death?'}
294
- ```
295
-
296
-
297
- ### Data Fields
298
-
299
- * **NER**
300
- * `id`: string
301
- * `ner_tags`: Sequence[ClassLabel]
302
- * `tokens`: Sequence[String]
303
- * **PICO**
304
- * To be added
305
- * **Relation Extraction**
306
- * To be added
307
- * **Sentence Similarity**
308
- * `sentence 1`: string
309
- * `sentence 2`: string
310
- * `score`: float ranging from 0 (no relation) to 4 (equivalent)
311
- * **Document Classification**
312
- * To be added
313
- * **Question Answering**
314
- * PubMedQA
315
- * `pubid`: integer
316
- * `question`: string
317
- * `context`: sequence of strings [`contexts`, `labels`, `meshes`, `reasoning_required_pred`, `reasoning_free_pred`]
318
- * `long_answer`: string
319
- * `final_decision`: string
320
-
321
- ### Data Splits
322
-
323
- Shown in the table of supported tasks.
324
-
325
- ## Dataset Creation
326
-
327
- ### Curation Rationale
328
-
329
- * BC5-chem
330
- * BC5-disease
331
- * BC2GM
332
- * JNLPBA
333
- * EBM PICO
334
- * ChemProt
335
- * DDI
336
- * GAD
337
- * BIOSSES
338
- * HoC
339
- * PubMedQA
340
- * BioASQ
341
-
342
- ### Source Data
343
-
344
- [More Information Needed]
345
-
346
- ### Annotations
347
-
348
- All the datasets have been obtained and annotated by experts in the biomedical domain. Check the different citations for further details.
349
-
350
- #### Annotation process
351
-
352
- * BC5-chem
353
- * BC5-disease
354
- * BC2GM
355
- * JNLPBA
356
- * EBM PICO
357
- * ChemProt
358
- * DDI
359
- * GAD
360
- * BIOSSES - The sentence pairs were evaluated by five different human experts that judged their similarity and gave scores ranging from 0 (no relation) to 4 (equivalent). The score range was described based on the guidelines of SemEval 2012 Task 6 on STS (Agirre et al., 2012). Besides the annotation instructions, example sentences from the biomedical literature were provided to the annotators for each of the similarity degrees.
361
- * HoC
362
- * PubMedQA
363
- * BioASQ
364
-
365
- ### Dataset Curators
366
-
367
- All the datasets have been obtained and annotated by experts in thebiomedical domain. Check the different citations for further details.
368
-
369
- ### Licensing Information
370
-
371
- * BC5-chem
372
- * BC5-disease
373
- * BC2GM
374
- * JNLPBA
375
- * EBM PICO
376
- * ChemProt
377
- * DDI
378
- * GAD
379
- * BIOSSES - BIOSSES is made available under the terms of [The GNU Common Public License v.3.0](https://www.gnu.org/licenses/gpl-3.0.en.html).
380
- * HoC
381
- * PubMedQA - MIT License Copyright (c) 2019 pubmedqa
382
- * BioASQ
383
-
384
- ### Citation Information
385
-
386
- * BC5-chem & BC5-disease
387
- ```latex
388
- @article{article,
389
- author = {Li, Jiao and Sun, Yueping and Johnson, Robin and Sciaky, Daniela and Wei, Chih-Hsuan and Leaman, Robert and Davis, Allan Peter and Mattingly, Carolyn and Wiegers, Thomas and lu, Zhiyong},
390
- year = {2016},
391
- month = {05},
392
- pages = {baw068},
393
- title = {BioCreative V CDR task corpus: a resource for chemical disease relation extraction},
394
- volume = {2016},
395
- journal = {Database},
396
- doi = {10.1093/database/baw068}
397
- }
398
- ```
399
- * BC2GM
400
- ```latex
401
- @article{article,
402
- author = {Smith, Larry and Tanabe, Lorraine and Ando, Rie and Kuo, Cheng-Ju and Chung, I-Fang and Hsu, Chun-Nan and Lin, Yu-Shi and Klinger, Roman and Friedrich, Christoph and Ganchev, Kuzman and Torii, Manabu and Liu, Hongfang and Haddow, Barry and Struble, Craig and Povinelli, Richard and Vlachos, Andreas and Baumgartner Jr, William and Hunter, Lawrence and Carpenter, Bob and Wilbur, W.},
403
- year = {2008},
404
- month = {09},
405
- pages = {S2},
406
- title = {Overview of BioCreative II gene mention recognition},
407
- volume = {9 Suppl 2},
408
- journal = {Genome biology},
409
- doi = {10.1186/gb-2008-9-s2-s2}
410
- }
411
- ```
412
- * JNLPBA
413
- ```latex
414
- @inproceedings{collier-kim-2004-introduction,
415
- title = "Introduction to the Bio-entity Recognition Task at {JNLPBA}",
416
- author = "Collier, Nigel and
417
- Kim, Jin-Dong",
418
- booktitle = "Proceedings of the International Joint Workshop on Natural Language Processing in Biomedicine and its Applications ({NLPBA}/{B}io{NLP})",
419
- month = aug # " 28th and 29th",
420
- year = "2004",
421
- address = "Geneva, Switzerland",
422
- publisher = "COLING",
423
- url = "https://aclanthology.org/W04-1213",
424
- pages = "73--78",
425
- }
426
- ```
427
- * NCBI Disiease
428
- ```latex
429
- @article{10.5555/2772763.2772800,
430
- author = {Dogan, Rezarta Islamaj and Leaman, Robert and Lu, Zhiyong},
431
- title = {NCBI Disease Corpus},
432
- year = {2014},
433
- issue_date = {February 2014},
434
- publisher = {Elsevier Science},
435
- address = {San Diego, CA, USA},
436
- volume = {47},
437
- number = {C},
438
- issn = {1532-0464},
439
- abstract = {Graphical abstractDisplay Omitted NCBI disease corpus is built as a gold-standard resource for disease recognition.793 PubMed abstracts are annotated with disease mentions and concepts (MeSH/OMIM).14 Annotators produced high consistency level and inter-annotator agreement.Normalization benchmark results demonstrate the utility of the corpus.The corpus is publicly available to the community. Information encoded in natural language in biomedical literature publications is only useful if efficient and reliable ways of accessing and analyzing that information are available. Natural language processing and text mining tools are therefore essential for extracting valuable information, however, the development of powerful, highly effective tools to automatically detect central biomedical concepts such as diseases is conditional on the availability of annotated corpora.This paper presents the disease name and concept annotations of the NCBI disease corpus, a collection of 793 PubMed abstracts fully annotated at the mention and concept level to serve as a research resource for the biomedical natural language processing community. Each PubMed abstract was manually annotated by two annotators with disease mentions and their corresponding concepts in Medical Subject Headings (MeSH ) or Online Mendelian Inheritance in Man (OMIM ). Manual curation was performed using PubTator, which allowed the use of pre-annotations as a pre-step to manual annotations. Fourteen annotators were randomly paired and differing annotations were discussed for reaching a consensus in two annotation phases. In this setting, a high inter-annotator agreement was observed. Finally, all results were checked against annotations of the rest of the corpus to assure corpus-wide consistency.The public release of the NCBI disease corpus contains 6892 disease mentions, which are mapped to 790 unique disease concepts. Of these, 88% link to a MeSH identifier, while the rest contain an OMIM identifier. We were able to link 91% of the mentions to a single disease concept, while the rest are described as a combination of concepts. In order to help researchers use the corpus to design and test disease identification methods, we have prepared the corpus as training, testing and development sets. To demonstrate its utility, we conducted a benchmarking experiment where we compared three different knowledge-based disease normalization methods with a best performance in F-measure of 63.7%. These results show that the NCBI disease corpus has the potential to significantly improve the state-of-the-art in disease name recognition and normalization research, by providing a high-quality gold standard thus enabling the development of machine-learning based approaches for such tasks.The NCBI disease corpus, guidelines and other associated resources are available at: http://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/.},
440
- journal = {J. of Biomedical Informatics},
441
- month = {feb},
442
- pages = {1–10},
443
- numpages = {10}}
444
- ```
445
- * EBM PICO
446
- * ChemProt
447
- * DDI
448
- * GAD
449
- * BIOSSES
450
- ```latex
451
- @article{souganciouglu2017biosses,
452
- title={BIOSSES: a semantic sentence similarity estimation system for the biomedical domain},
453
- author={So{\u{g}}anc{\i}o{\u{g}}lu, Gizem and {\"O}zt{\"u}rk, Hakime and {\"O}zg{\"u}r, Arzucan},
454
- journal={Bioinformatics},
455
- volume={33},
456
- number={14},
457
- pages={i49--i58},
458
- year={2017},
459
- publisher={Oxford University Press}
460
- }
461
-
462
- ```
463
- * HoC
464
- * PubMedQA
465
- ```latex
466
- @inproceedings{jin2019pubmedqa,
467
- title={PubMedQA: A Dataset for Biomedical Research Question Answering},
468
- author={Jin, Qiao and Dhingra, Bhuwan and Liu, Zhengping and Cohen, William and Lu, Xinghua},
469
- booktitle={Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP-IJCNLP)},
470
- pages={2567--2577},
471
- year={2019}
472
- }
473
- ```
474
-
475
- * BioASQ
476
- ```latex
477
- @article{10.1093/bioinformatics/btv585,
478
- author = {Baker, Simon and Silins, Ilona and Guo, Yufan and Ali, Imran and Högberg, Johan and Stenius, Ulla and Korhonen, Anna},
479
- title = "{Automatic semantic classification of scientific literature according to the hallmarks of cancer}",
480
- journal = {Bioinformatics},
481
- volume = {32},
482
- number = {3},
483
- pages = {432-440},
484
- year = {2015},
485
- month = {10},
486
- abstract = "{Motivation: The hallmarks of cancer have become highly influential in cancer research. They reduce the complexity of cancer into 10 principles (e.g. resisting cell death and sustaining proliferative signaling) that explain the biological capabilities acquired during the development of human tumors. Since new research depends crucially on existing knowledge, technology for semantic classification of scientific literature according to the hallmarks of cancer could greatly support literature review, knowledge discovery and applications in cancer research.Results: We present the first step toward the development of such technology. We introduce a corpus of 1499 PubMed abstracts annotated according to the scientific evidence they provide for the 10 currently known hallmarks of cancer. We use this corpus to train a system that classifies PubMed literature according to the hallmarks. The system uses supervised machine learning and rich features largely based on biomedical text mining. We report good performance in both intrinsic and extrinsic evaluations, demonstrating both the accuracy of the methodology and its potential in supporting practical cancer research. We discuss how this approach could be developed and applied further in the future.Availability and implementation: The corpus of hallmark-annotated PubMed abstracts and the software for classification are available at: http://www.cl.cam.ac.uk/∼sb895/HoC.html .Contact:simon.baker@cl.cam.ac.uk}",
487
- issn = {1367-4803},
488
- doi = {10.1093/bioinformatics/btv585},
489
- url = {https://doi.org/10.1093/bioinformatics/btv585},
490
- eprint = {https://academic.oup.com/bioinformatics/article-pdf/32/3/432/19568147/btv585.pdf},
491
- }
492
- ```
493
-
494
- ### Contributions
495
- * This dataset has been uploaded and generated by Dr. Jorge Abreu Vicente.
496
- * Thanks to [@GamalC](https://github.com/GamalC) for uploading the NER datasets to GitHub, from where I got them.
497
- * I am not part of the team that generated BLURB. This dataset is intended to help researchers to usethe BLURB benchmarking for NLP in Biomedical NLP.
498
- * Thanks to [@bwang482](https://github.com/bwang482) for uploading the [BIOSSES dataset](https://github.com/bwang482/datasets/tree/master/datasets/biosses). We forked the [BIOSSES 🤗 dataset](https://huggingface.co/datasets/biosses) to add it to this BLURB benchmark.
499
  * Thank you to [@tuner007](https://github.com/tuner007) for adding this dataset to the 🤗 hub
1
+ ---
2
+ license: apache-2.0
3
+ annotations_creators:
4
+ - expert-generated
5
+ language_creators:
6
+ - expert-generated
7
+ language:
8
+ - en
9
+ multilinguality:
10
+ - monolingual
11
+ paperswithcode_id: null
12
+ pretty_name: BLURB (Biomedical Language Understanding and Reasoning Benchmark.)
13
+ size_categories:
14
+ - 10K<n<100K
15
+ source_datasets:
16
+ - original
17
+ task_categories:
18
+ - structure-prediction
19
+ - question-answering
20
+ - text-scoring
21
+ - text-classification
22
+ task_ids:
23
+ - named-entity-recognition
24
+ - parsing
25
+ - closed-domain-qa
26
+ - semantic-similarity-scoring
27
+ - text-scoring-other-sentence-similrity
28
+ - topic-classificatio
29
+ ---
30
+
31
+ # Dataset Card for BLURB
32
+
33
+ ## Table of Contents
34
+ - [Table of Contents](#table-of-contents)
35
+ - [Dataset Description](#dataset-description)
36
+ - [Dataset Summary](#dataset-summary)
37
+ - [Supported Tasks and Leaderboards](#supported-tasks-and-leaderboards)
38
+ - [Languages](#languages)
39
+ - [Dataset Structure](#dataset-structure)
40
+ - [Data Instances](#data-instances)
41
+ - [Data Fields](#data-fields)
42
+ - [Data Splits](#data-splits)
43
+ - [Dataset Creation](#dataset-creation)
44
+ - [Curation Rationale](#curation-rationale)
45
+ - [Source Data](#source-data)
46
+ - [Annotations](#annotations)
47
+ - [Personal and Sensitive Information](#personal-and-sensitive-information)
48
+ - [Considerations for Using the Data](#considerations-for-using-the-data)
49
+ - [Social Impact of Dataset](#social-impact-of-dataset)
50
+ - [Discussion of Biases](#discussion-of-biases)
51
+ - [Other Known Limitations](#other-known-limitations)
52
+ - [Additional Information](#additional-information)
53
+ - [Dataset Curators](#dataset-curators)
54
+ - [Licensing Information](#licensing-information)
55
+ - [Citation Information](#citation-information)
56
+ - [Contributions](#contributions)
57
+
58
+ ## Dataset Description
59
+
60
+ - **Homepage:** https://microsoft.github.io/BLURB/index.html
61
+ - **Paper:** [Domain-Specific Language Model Pretraining for Biomedical Natural Language Processing](https://arxiv.org/pdf/2007.15779.pdf)
62
+ - **Leaderboard:** https://microsoft.github.io/BLURB/leaderboard.html
63
+ - **Point of Contact:**
64
+
65
+ ### Dataset Summary
66
+
67
+ BLURB is a collection of resources for biomedical natural language processing. In general domains, such as newswire and the Web, comprehensive benchmarks and leaderboards such as GLUE have greatly accelerated progress in open-domain NLP. In biomedicine, however, such resources are ostensibly scarce. In the past, there have been a plethora of shared tasks in biomedical NLP, such as BioCreative, BioNLP Shared Tasks, SemEval, and BioASQ, to name just a few. These efforts have played a significant role in fueling interest and progress by the research community, but they typically focus on individual tasks. The advent of neural language models, such as BERT provides a unifying foundation to leverage transfer learning from unlabeled text to support a wide range of NLP applications. To accelerate progress in biomedical pretraining strategies and task-specific methods, it is thus imperative to create a broad-coverage benchmark encompassing diverse biomedical tasks.
68
+
69
+ Inspired by prior efforts toward this direction (e.g., BLUE), we have created BLURB (short for Biomedical Language Understanding and Reasoning Benchmark). BLURB comprises of a comprehensive benchmark for PubMed-based biomedical NLP applications, as well as a leaderboard for tracking progress by the community. BLURB includes thirteen publicly available datasets in six diverse tasks. To avoid placing undue emphasis on tasks with many available datasets, such as named entity recognition (NER), BLURB reports the macro average across all tasks as the main score. The BLURB leaderboard is model-agnostic. Any system capable of producing the test predictions using the same training and development data can participate. The main goal of BLURB is to lower the entry barrier in biomedical NLP and help accelerate progress in this vitally important field for positive societal and human impact.
70
+
71
+
72
+ #### BC5-chem
73
+ The corpus consists of three separate sets of
74
+ articles with diseases, chemicals and their relations annotated.
75
+ The training (500 articles) and development (500 articles) sets
76
+ were released to task participants in advance to support text-mining
77
+ method development. The test set (500 articles) was used for final
78
+ system performance evaluation.
79
+
80
+ - **Homepage:** https://biocreative.bioinformatics.udel.edu/resources/corpora/biocreative-v-cdr-corpus
81
+ - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
82
+ - **Paper:** [BioCreative V CDR task corpus: a resource for chemical disease relation extraction](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860626/)
83
+
84
+ #### BC5-disease
85
+ The corpus consists of three separate sets of
86
+ articles with diseases, chemicals and their relations annotated.
87
+ The training (500 articles) and development (500 articles) sets
88
+ were released to task participants in advance to support text-mining
89
+ method development. The test set (500 articles) was used for final
90
+ system performance evaluation.
91
+
92
+ - **Homepage:** https://biocreative.bioinformatics.udel.edu/resources/corpora/biocreative-v-cdr-corpus
93
+ - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
94
+ - **Paper:** [BioCreative V CDR task corpus: a resource for chemical disease relation extraction](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860626/)
95
+
96
+ #### BC2GM
97
+ The BioCreative II Gene Mention task.
98
+ The training corpus for the current task consists mainly of
99
+ the training and testing corpora (text collections) from the
100
+ BCI task, and the testing corpus for the current task
101
+ consists of an additional 5,000 sentences that were held
102
+ 'in reserve' from the previous task.
103
+ In the current corpus, tokenization is not provided;
104
+ instead participants are asked to identify a gene mention
105
+ in a sentence by giving its start and end characters.
106
+ As before, the training set consists of a set of sentences,
107
+ and for each sentence a set of gene mentions
108
+ (GENE annotations).
109
+ - **Homepage:** https://biocreative.bioinformatics.udel.edu/tasks/biocreative-ii/task-1a-gene-mention-tagging/
110
+ - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
111
+ - **Paper:** [verview of BioCreative II gene mention recognition](https://link.springer.com/article/10.1186/gb-2008-9-s2-s2)
112
+
113
+ #### NCBI Disease
114
+
115
+ The NCBI disease corpus is fully annotated at the mention
116
+ and concept level to serve as a research resource for the biomedical natural
117
+ language processing community.
118
+ Corpus Characteristics
119
+ ----------------------
120
+ * 793 PubMed abstracts
121
+ * 6,892 disease mentions
122
+ * 790 unique disease concepts
123
+ * Medical Subject Headings (MeSH®)
124
+ * Online Mendelian Inheritance in Man (OMIM®)
125
+ * 91% of the mentions map to a single disease concept
126
+ **divided into training, developing and testing sets.
127
+ Corpus Annotation
128
+ * Fourteen annotators
129
+ * Two-annotators per document (randomly paired)
130
+ * Three annotation phases
131
+ * Checked for corpus-wide consistency of annotations
132
+ - **Homepage:** https://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/
133
+ - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
134
+ - **Paper:** [NCBI disease corpus: a resource for disease name recognition and concept normalization](https://pubmed.ncbi.nlm.nih.gov/24393765/)
135
+
136
+ #### JNLPBA
137
+ The BioNLP / JNLPBA Shared Task 2004 involves the identification
138
+ and classification of technical terms referring to concepts of interest to
139
+ biologists in the domain of molecular biology. The task was organized by GENIA
140
+ Project based on the annotations of the GENIA Term corpus (version 3.02).
141
+ Corpus format: The JNLPBA corpus is distributed in IOB format, with each line
142
+ containing a single token and its tag, separated by a tab character.
143
+ Sentences are separated by blank lines.
144
+ - **Homepage: ** http://www.geniaproject.org/shared-tasks/bionlp-jnlpba-shared-task-2004
145
+ - **Repository:** [NER GitHub repo by @GamalC](https://github.com/cambridgeltl/MTL-Bioinformatics-2016/raw/master/data/)
146
+ - **Paper: ** [Introduction to the Bio-entity Recognition Task at JNLPBA](https://aclanthology.org/W04-1213)
147
+
148
+ #### EBM PICO
149
+ - **Homepage:**
150
+ - **Repository:**
151
+ - **Paper:**
152
+ - **Leaderboard:**
153
+
154
+ #### ChemProt
155
+ - **Homepage:**
156
+ - **Repository:**
157
+ - **Paper:**
158
+
159
+ #### DDI
160
+ - **Homepage:**
161
+ - **Repository:**
162
+ - **Paper:**
163
+
164
+ #### GAD
165
+ - **Homepage:**
166
+ - **Repository:**
167
+ - **Paper:**
168
+
169
+ #### BIOSSES
170
+
171
+ BIOSSES is a benchmark dataset for biomedical sentence similarity estimation. The dataset comprises 100 sentence pairs, in which each sentence was selected from the [TAC (Text Analysis Conference) Biomedical Summarization Track Training Dataset](https://tac.nist.gov/2014/BiomedSumm/) containing articles from the biomedical domain. The sentence pairs in BIOSSES were selected from citing sentences, i.e. sentences that have a citation to a reference article.
172
+ The sentence pairs were evaluated by five different human experts that judged their similarity and gave scores ranging from 0 (no relation) to 4 (equivalent). In the original paper the mean of the scores assigned by the five human annotators was taken as the gold standard. The Pearson correlation between the gold standard scores and the scores estimated by the models was used as the evaluation metric. The strength of correlation can be assessed by the general guideline proposed by Evans (1996) as follows:
173
+ - very strong: 0.80–1.00
174
+ - strong: 0.60–0.79
175
+ - moderate: 0.400.59
176
+ - weak: 0.20–0.39
177
+ - very weak: 0.00–0.19
178
+
179
+ - **Homepage:** https://tabilab.cmpe.boun.edu.tr/BIOSSES/DataSet.html
180
+ - **Repository:** https://github.com/gizemsogancioglu/biosses
181
+ - **Paper:** [BIOSSES: a semantic sentence similarity estimation system for the biomedical domain](https://academic.oup.com/bioinformatics/article/33/14/i49/3953954)
182
+ - **Point of Contact:** [Gizem Soğancıoğlu](gizemsogancioglu@gmail.com) and [Arzucan Özgür](gizemsogancioglu@gmail.com)
183
+
184
+ #### HoC
185
+ - **Homepage:**
186
+ - **Repository:**
187
+ - **Paper:**
188
+ - **Leaderboard:**
189
+ - **Point of Contact:**
190
+
191
+
192
+ #### PubMedQA
193
+
194
+ We introduce PubMedQA, a novel biomedical question answering (QA) dataset collected from PubMed abstracts. The task of PubMedQA is to answer research questions with yes/no/maybe (e.g.: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?) using the corresponding abstracts. PubMedQA has 1k expert-annotated, 61.2k unlabeled and 211.3k artificially generated QA instances. Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion. PubMedQA is the first QA dataset where reasoning over biomedical research texts, especially their quantitative contents, is required to answer the questions. Our best performing model, multi-phase fine-tuning of BioBERT with long answer bag-of-word statistics as additional supervision, achieves 68.1% accuracy, compared to single human performance of 78.0% accuracy and majority-baseline of 55.2% accuracy, leaving much room for improvement. PubMedQA is publicly available at this https URL.
195
+
196
+ - **Homepage:** https://pubmedqa.github.io/
197
+ - **Repository:** https://github.com/pubmedqa/pubmedqa
198
+ - **Paper:** [PubMedQA: A Dataset for Biomedical Research Question Answering](https://arxiv.org/pdf/1909.06146.pdf)
199
+ - **Leaderboard:** [Question answering](https://pubmedqa.github.io/)
200
+ - **Point of Contact:**
201
+
202
+ #### BioASQ
203
+
204
+ Task 7b will use benchmark datasets containing training and test biomedical questions, in English, along with gold standard (reference) answers. The participants will have to respond to each test question with relevant concepts (from designated terminologies and ontologies), relevant articles (in English, from designated article repositories), relevant snippets (from the relevant articles), relevant RDF triples (from designated ontologies), exact answers (e.g., named entities in the case of factoid questions) and 'ideal' answers (English paragraph-sized summaries). 2747 training questions (that were used as dry-run or test questions in previous year) are already available, along with their gold standard answers (relevant concepts, articles, snippets, exact answers, summaries).
205
+
206
+ - **Homepage:** http://bioasq.org/
207
+ - **Repository:** http://participants-area.bioasq.org/datasets/
208
+ - **Paper:** [Automatic semantic classification of scientific literature according to the hallmarks of cancer](https://academic.oup.com/bioinformatics/article/32/3/432/1743783?login=false)
209
+
210
+ ### Supported Tasks and Leaderboards
211
+
212
+ | **Dataset** | **Task** | **Train** | **Dev** | **Test** | **Evaluation Metrics** | **Added** |
213
+ |:------------:|:-----------------------:|:---------:|:-------:|:--------:|:----------------------:|-----------|
214
+ | BC5-chem | NER | 5203 | 5347 | 5385 | F1 entity-level | **Yes** |
215
+ | BC5-disease | NER | 4182 | 4244 | 4424 | F1 entity-level | **Yes** |
216
+ | NCBI-disease | NER | 5134 | 787 | 960 | F1 entity-level | **Yes** |
217
+ | BC2GM | NER | 15197 | 3061 | 6325 | F1 entity-level | **Yes** |
218
+ | JNLPBA | NER | 46750 | 4551 | 8662 | F1 entity-level | **Yes** |
219
+ | EBM PICO | PICO | 339167 | 85321 | 16364 | Macro F1 word-level | No |
220
+ | ChemProt | Relation Extraction | 18035 | 11268 | 15745 | Micro F1 | No |
221
+ | DDI | Relation Extraction | 25296 | 2496 | 5716 | Micro F1 | No |
222
+ | GAD | Relation Extraction | 4261 | 535 | 534 | Micro F1 | No |
223
+ | BIOSSES | Sentence Similarity | 64 | 16 | 20 | Pearson | **Yes** |
224
+ | HoC | Document Classification | 1295 | 186 | 371 | Average Micro F1 | No |
225
+ | PubMedQA | Question Answering | 450 | 50 | 500 | Accuracy | **Yes** |
226
+ | BioASQ | Question Answering | 670 | 75 | 140 | Accuracy | No |
227
+
228
+ Datasets used in the BLURB biomedical NLP benchmark. The Train, Dev, and test splits might not be exactly identical to those proposed in BLURB.
229
+ This is something to be checked.
230
+
231
+ ### Languages
232
+
233
+ English from biomedical texts
234
+
235
+ ## Dataset Structure
236
+
237
+ ### Data Instances
238
+
239
+ * **NER**
240
+ ```json
241
+ {
242
+ 'id': 0,
243
+ 'tokens': [ "DPP6", "as", "a", "candidate", "gene", "for", "neuroleptic", "-", "induced", "tardive", "dyskinesia", "." ]
244
+ 'ner_tags': [ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
245
+ }
246
+ ```
247
+ * **PICO**
248
+ ```json
249
+ {
250
+ 'TBD'
251
+ }
252
+ ```
253
+ * **Relation Extraction**
254
+ ```json
255
+ {
256
+ 'TBD'
257
+ }
258
+ ```
259
+
260
+ * **Sentence Similarity**
261
+
262
+ ```json
263
+ {'sentence 1': 'Here, looking for agents that could specifically kill KRAS mutant cells, they found that knockdown of GATA2 was synthetically lethal with KRAS mutation'
264
+ 'sentence 2': 'Not surprisingly, GATA2 knockdown in KRAS mutant cells resulted in a striking reduction of active GTP-bound RHO proteins, including the downstream ROCK kinase'
265
+ 'score': 2.2}
266
+ ```
267
+
268
+ * **Document Classification**
269
+ ```json
270
+ {
271
+ 'TBD'
272
+ }
273
+ ```
274
+ * **Question Answering**
275
+
276
+ * PubMedQA
277
+ ```json
278
+ {'context': {'contexts': ['Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of a latticework of longitudinal and transverse veins enclosing areoles. PCD occurs in the cells at the center of these areoles and progresses outwards, stopping approximately five cells from the vasculature. The role of mitochondria during PCD has been recognized in animals; however, it has been less studied during PCD in plants.',
279
+ 'The following paper elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis. A single areole within a window stage leaf (PCD is occurring) was divided into three areas based on the progression of PCD; cells that will not undergo PCD (NPCD), cells in early stages of PCD (EPCD), and cells in late stages of PCD (LPCD). Window stage leaves were stained with the mitochondrial dye MitoTracker Red CMXRos and examined. Mitochondrial dynamics were delineated into four categories (M1-M4) based on characteristics including distribution, motility, and membrane potential (ΔΨm). A TUNEL assay showed fragmented nDNA in a gradient over these mitochondrial stages. Chloroplasts and transvacuolar strands were also examined using live cell imaging. The possible importance of mitochondrial permeability transition pore (PTP) formation during PCD was indirectly examined via in vivo cyclosporine A (CsA) treatment. This treatment resulted in lace plant leaves with a significantly lower number of perforations compared to controls, and that displayed mitochondrial dynamics similar to that of non-PCD cells.'],
280
+ 'labels': ['BACKGROUND', 'RESULTS'],
281
+ 'meshes': ['Alismataceae',
282
+ 'Apoptosis',
283
+ 'Cell Differentiation',
284
+ 'Mitochondria',
285
+ 'Plant Leaves'],
286
+ 'reasoning_free_pred': ['y', 'e', 's'],
287
+ 'reasoning_required_pred': ['y', 'e', 's']},
288
+ 'final_decision': 'yes',
289
+ 'long_answer': 'Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace plant, and highlight the correlation of this organelle with other organelles during developmental PCD. To the best of our knowledge, this is the first report of mitochondria and chloroplasts moving on transvacuolar strands to form a ring structure surrounding the nucleus during developmental PCD. Also, for the first time, we have shown the feasibility for the use of CsA in a whole plant system. Overall, our findings implicate the mitochondria as playing a critical and early role in developmentally regulated PCD in the lace plant.',
290
+ 'pubid': 21645374,
291
+ 'question': 'Do mitochondria play a role in remodelling lace plant leaves during programmed cell death?'}
292
+ ```
293
+
294
+
295
+ ### Data Fields
296
+
297
+ * **NER**
298
+ * `id`: string
299
+ * `ner_tags`: Sequence[ClassLabel]
300
+ * `tokens`: Sequence[String]
301
+ * **PICO**
302
+ * To be added
303
+ * **Relation Extraction**
304
+ * To be added
305
+ * **Sentence Similarity**
306
+ * `sentence 1`: string
307
+ * `sentence 2`: string
308
+ * `score`: float ranging from 0 (no relation) to 4 (equivalent)
309
+ * **Document Classification**
310
+ * To be added
311
+ * **Question Answering**
312
+ * PubMedQA
313
+ * `pubid`: integer
314
+ * `question`: string
315
+ * `context`: sequence of strings [`contexts`, `labels`, `meshes`, `reasoning_required_pred`, `reasoning_free_pred`]
316
+ * `long_answer`: string
317
+ * `final_decision`: string
318
+
319
+ ### Data Splits
320
+
321
+ Shown in the table of supported tasks.
322
+
323
+ ## Dataset Creation
324
+
325
+ ### Curation Rationale
326
+
327
+ * BC5-chem
328
+ * BC5-disease
329
+ * BC2GM
330
+ * JNLPBA
331
+ * EBM PICO
332
+ * ChemProt
333
+ * DDI
334
+ * GAD
335
+ * BIOSSES
336
+ * HoC
337
+ * PubMedQA
338
+ * BioASQ
339
+
340
+ ### Source Data
341
+
342
+ [More Information Needed]
343
+
344
+ ### Annotations
345
+
346
+ All the datasets have been obtained and annotated by experts in the biomedical domain. Check the different citations for further details.
347
+
348
+ #### Annotation process
349
+
350
+ * BC5-chem
351
+ * BC5-disease
352
+ * BC2GM
353
+ * JNLPBA
354
+ * EBM PICO
355
+ * ChemProt
356
+ * DDI
357
+ * GAD
358
+ * BIOSSES - The sentence pairs were evaluated by five different human experts that judged their similarity and gave scores ranging from 0 (no relation) to 4 (equivalent). The score range was described based on the guidelines of SemEval 2012 Task 6 on STS (Agirre et al., 2012). Besides the annotation instructions, example sentences from the biomedical literature were provided to the annotators for each of the similarity degrees.
359
+ * HoC
360
+ * PubMedQA
361
+ * BioASQ
362
+
363
+ ### Dataset Curators
364
+
365
+ All the datasets have been obtained and annotated by experts in thebiomedical domain. Check the different citations for further details.
366
+
367
+ ### Licensing Information
368
+
369
+ * BC5-chem
370
+ * BC5-disease
371
+ * BC2GM
372
+ * JNLPBA
373
+ * EBM PICO
374
+ * ChemProt
375
+ * DDI
376
+ * GAD
377
+ * BIOSSES - BIOSSES is made available under the terms of [The GNU Common Public License v.3.0](https://www.gnu.org/licenses/gpl-3.0.en.html).
378
+ * HoC
379
+ * PubMedQA - MIT License Copyright (c) 2019 pubmedqa
380
+ * BioASQ
381
+
382
+ ### Citation Information
383
+
384
+ * BC5-chem & BC5-disease
385
+ ```latex
386
+ @article{article,
387
+ author = {Li, Jiao and Sun, Yueping and Johnson, Robin and Sciaky, Daniela and Wei, Chih-Hsuan and Leaman, Robert and Davis, Allan Peter and Mattingly, Carolyn and Wiegers, Thomas and lu, Zhiyong},
388
+ year = {2016},
389
+ month = {05},
390
+ pages = {baw068},
391
+ title = {BioCreative V CDR task corpus: a resource for chemical disease relation extraction},
392
+ volume = {2016},
393
+ journal = {Database},
394
+ doi = {10.1093/database/baw068}
395
+ }
396
+ ```
397
+ * BC2GM
398
+ ```latex
399
+ @article{article,
400
+ author = {Smith, Larry and Tanabe, Lorraine and Ando, Rie and Kuo, Cheng-Ju and Chung, I-Fang and Hsu, Chun-Nan and Lin, Yu-Shi and Klinger, Roman and Friedrich, Christoph and Ganchev, Kuzman and Torii, Manabu and Liu, Hongfang and Haddow, Barry and Struble, Craig and Povinelli, Richard and Vlachos, Andreas and Baumgartner Jr, William and Hunter, Lawrence and Carpenter, Bob and Wilbur, W.},
401
+ year = {2008},
402
+ month = {09},
403
+ pages = {S2},
404
+ title = {Overview of BioCreative II gene mention recognition},
405
+ volume = {9 Suppl 2},
406
+ journal = {Genome biology},
407
+ doi = {10.1186/gb-2008-9-s2-s2}
408
+ }
409
+ ```
410
+ * JNLPBA
411
+ ```latex
412
+ @inproceedings{collier-kim-2004-introduction,
413
+ title = "Introduction to the Bio-entity Recognition Task at {JNLPBA}",
414
+ author = "Collier, Nigel and
415
+ Kim, Jin-Dong",
416
+ booktitle = "Proceedings of the International Joint Workshop on Natural Language Processing in Biomedicine and its Applications ({NLPBA}/{B}io{NLP})",
417
+ month = aug # " 28th and 29th",
418
+ year = "2004",
419
+ address = "Geneva, Switzerland",
420
+ publisher = "COLING",
421
+ url = "https://aclanthology.org/W04-1213",
422
+ pages = "73--78",
423
+ }
424
+ ```
425
+ * NCBI Disiease
426
+ ```latex
427
+ @article{10.5555/2772763.2772800,
428
+ author = {Dogan, Rezarta Islamaj and Leaman, Robert and Lu, Zhiyong},
429
+ title = {NCBI Disease Corpus},
430
+ year = {2014},
431
+ issue_date = {February 2014},
432
+ publisher = {Elsevier Science},
433
+ address = {San Diego, CA, USA},
434
+ volume = {47},
435
+ number = {C},
436
+ issn = {1532-0464},
437
+ abstract = {Graphical abstractDisplay Omitted NCBI disease corpus is built as a gold-standard resource for disease recognition.793 PubMed abstracts are annotated with disease mentions and concepts (MeSH/OMIM).14 Annotators produced high consistency level and inter-annotator agreement.Normalization benchmark results demonstrate the utility of the corpus.The corpus is publicly available to the community. Information encoded in natural language in biomedical literature publications is only useful if efficient and reliable ways of accessing and analyzing that information are available. Natural language processing and text mining tools are therefore essential for extracting valuable information, however, the development of powerful, highly effective tools to automatically detect central biomedical concepts such as diseases is conditional on the availability of annotated corpora.This paper presents the disease name and concept annotations of the NCBI disease corpus, a collection of 793 PubMed abstracts fully annotated at the mention and concept level to serve as a research resource for the biomedical natural language processing community. Each PubMed abstract was manually annotated by two annotators with disease mentions and their corresponding concepts in Medical Subject Headings (MeSH ) or Online Mendelian Inheritance in Man (OMIM ). Manual curation was performed using PubTator, which allowed the use of pre-annotations as a pre-step to manual annotations. Fourteen annotators were randomly paired and differing annotations were discussed for reaching a consensus in two annotation phases. In this setting, a high inter-annotator agreement was observed. Finally, all results were checked against annotations of the rest of the corpus to assure corpus-wide consistency.The public release of the NCBI disease corpus contains 6892 disease mentions, which are mapped to 790 unique disease concepts. Of these, 88% link to a MeSH identifier, while the rest contain an OMIM identifier. We were able to link 91% of the mentions to a single disease concept, while the rest are described as a combination of concepts. In order to help researchers use the corpus to design and test disease identification methods, we have prepared the corpus as training, testing and development sets. To demonstrate its utility, we conducted a benchmarking experiment where we compared three different knowledge-based disease normalization methods with a best performance in F-measure of 63.7%. These results show that the NCBI disease corpus has the potential to significantly improve the state-of-the-art in disease name recognition and normalization research, by providing a high-quality gold standard thus enabling the development of machine-learning based approaches for such tasks.The NCBI disease corpus, guidelines and other associated resources are available at: http://www.ncbi.nlm.nih.gov/CBBresearch/Dogan/DISEASE/.},
438
+ journal = {J. of Biomedical Informatics},
439
+ month = {feb},
440
+ pages = {1–10},
441
+ numpages = {10}}
442
+ ```
443
+ * EBM PICO
444
+ * ChemProt
445
+ * DDI
446
+ * GAD
447
+ * BIOSSES
448
+ ```latex
449
+ @article{souganciouglu2017biosses,
450
+ title={BIOSSES: a semantic sentence similarity estimation system for the biomedical domain},
451
+ author={So{\u{g}}anc{\i}o{\u{g}}lu, Gizem and {\"O}zt{\"u}rk, Hakime and {\"O}zg{\"u}r, Arzucan},
452
+ journal={Bioinformatics},
453
+ volume={33},
454
+ number={14},
455
+ pages={i49--i58},
456
+ year={2017},
457
+ publisher={Oxford University Press}
458
+ }
459
+
460
+ ```
461
+ * HoC
462
+ * PubMedQA
463
+ ```latex
464
+ @inproceedings{jin2019pubmedqa,
465
+ title={PubMedQA: A Dataset for Biomedical Research Question Answering},
466
+ author={Jin, Qiao and Dhingra, Bhuwan and Liu, Zhengping and Cohen, William and Lu, Xinghua},
467
+ booktitle={Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing and the 9th International Joint Conference on Natural Language Processing (EMNLP-IJCNLP)},
468
+ pages={2567--2577},
469
+ year={2019}
470
+ }
471
+ ```
472
+
473
+ * BioASQ
474
+ ```latex
475
+ @article{10.1093/bioinformatics/btv585,
476
+ author = {Baker, Simon and Silins, Ilona and Guo, Yufan and Ali, Imran and Högberg, Johan and Stenius, Ulla and Korhonen, Anna},
477
+ title = "{Automatic semantic classification of scientific literature according to the hallmarks of cancer}",
478
+ journal = {Bioinformatics},
479
+ volume = {32},
480
+ number = {3},
481
+ pages = {432-440},
482
+ year = {2015},
483
+ month = {10},
484
+ abstract = "{Motivation: The hallmarks of cancer have become highly influential in cancer research. They reduce the complexity of cancer into 10 principles (e.g. resisting cell death and sustaining proliferative signaling) that explain the biological capabilities acquired during the development of human tumors. Since new research depends crucially on existing knowledge, technology for semantic classification of scientific literature according to the hallmarks of cancer could greatly support literature review, knowledge discovery and applications in cancer research.Results: We present the first step toward the development of such technology. We introduce a corpus of 1499 PubMed abstracts annotated according to the scientific evidence they provide for the 10 currently known hallmarks of cancer. We use this corpus to train a system that classifies PubMed literature according to the hallmarks. The system uses supervised machine learning and rich features largely based on biomedical text mining. We report good performance in both intrinsic and extrinsic evaluations, demonstrating both the accuracy of the methodology and its potential in supporting practical cancer research. We discuss how this approach could be developed and applied further in the future.Availability and implementation: The corpus of hallmark-annotated PubMed abstracts and the software for classification are available at: http://www.cl.cam.ac.uk/∼sb895/HoC.html .Contact:simon.baker@cl.cam.ac.uk}",
485
+ issn = {1367-4803},
486
+ doi = {10.1093/bioinformatics/btv585},
487
+ url = {https://doi.org/10.1093/bioinformatics/btv585},
488
+ eprint = {https://academic.oup.com/bioinformatics/article-pdf/32/3/432/19568147/btv585.pdf},
489
+ }
490
+ ```
491
+
492
+ ### Contributions
493
+ * This dataset has been uploaded and generated by Dr. Jorge Abreu Vicente.
494
+ * Thanks to [@GamalC](https://github.com/GamalC) for uploading the NER datasets to GitHub, from where I got them.
495
+ * I am not part of the team that generated BLURB. This dataset is intended to help researchers to usethe BLURB benchmarking for NLP in Biomedical NLP.
496
+ * Thanks to [@bwang482](https://github.com/bwang482) for uploading the [BIOSSES dataset](https://github.com/bwang482/datasets/tree/master/datasets/biosses). We forked the [BIOSSES 🤗 dataset](https://huggingface.co/datasets/biosses) to add it to this BLURB benchmark.
 
 
497
  * Thank you to [@tuner007](https://github.com/tuner007) for adding this dataset to the 🤗 hub